Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Psycho-Oncology|February 26, 2011
Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-studyC M T Schilder, C Seynaeve, S C Linn, et al.
Critical Reviews in Oncology/Hematology|December 29, 2009
Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factorsC M T Schilder, C Seynaeve, S C Linn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trialJ G H van Nes, C Seynaeve, E Maartense, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 24, 2014
Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancerA Charehbili, M N Wasser, V T H B M Smit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancerD W Rea, J W R Nortier, W W Ten Bokkel Huinink, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 13, 2020
Using a quality of life (QoL)-monitor: preliminary results of a randomized trial in Dutch patients with early breast cancerR T Lugtenberg, M J Fischer, F de Jongh, et al.
Molecular Oncology|March 5, 2015
Disorganised stroma determined on pre-treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trialT J A Dekker, A Charehbili, V T H B M Smit, et al.
Breast Cancer Research and Treatment|March 29, 2012
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side studyJ G H van Nes, D B Y Fontein, E T M Hille, et al.
Breast Cancer Research and Treatment|August 2, 2017
Cross-cultural comparison of breast cancer patients' Quality of Life in the Netherlands and JapanM J Fischer, K Inoue, A Matsuda, et al.
Critical Reviews in Oncology/Hematology|August 17, 2010
Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapyA A Aaldriks, E Maartense, S le Cessie, et al.
Pageof 8